AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 09-E-05-018.07
FDA should require that sponsors submit financial information for clinical investigators as part of the pretrial application process.
The publisher's file lists July 2, 2025 as the date the next update was expected. That date has passed. This is the publisher's own date field, not a finding that anyone missed a deadline.
The recommendation, in the publisher's words
FDA should require that sponsors submit financial information for clinical investigators as part of the pretrial application process.
- Responsible agency
- Food and Drug Administration
- Issued
- January 9, 2009
- Report
- The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information (OEI-05-07-00730) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Non-Concur (as recorded by the publisher)
- Last update received
- May 23, 2024
- Next update expected
- July 2, 2025 (publisher's date)
- Publisher topics
- Food; Drug and Device Safety
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.